Wall Street Bulls Look Optimistic About Lilly (LLY): Should You Buy?

The article examines the reliability of Wall Street analyst recommendations versus the Zacks Rank system. While Eli Lilly has a strong average brokerage recommendation (ABR) of 1.45 (Buy-equivalent), the article cautions that brokerage analysts often exhibit positive bias due to vested interests. In contrast, the Zacks Rank, which is based on earnings estimate revisions, has demonstrated superior predictive power for near-term stock price movements. Lilly's unchanged consensus estimate resulted in a Zacks Rank #3 (Hold), suggesting caution despite the bullish ABR.